img

Bicalutamide-antiandrogen medication that is primarily used to treat prostate cancer.

Bicalutamide, sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer. It is typically used together with a gonadotropin-releasing hormone (GnRH) analogue or surgical removal of the testicles to treat metastatic prostate cancer. More

Sharing is caring, show love and share the thread with your friends.

Description

Bicalutamide, sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer. It is typically used together with a gonadotropin-releasing hormone (GnRH) analogue or surgical removal of the testicles to treat metastatic prostate cancer.

Generic Name

Bicalutamide-antiandrogen medication that is primarily used to treat prostate cancer.

Chemical names

Casodex; Cosudex; ICI 176334

Brand names

Androblok, Bicalon, Biprosta, Caludec, Caluran, Caluran-CP, Calutide-50, Casodex, Cluta-B, Cosalon, Utamide

IUPAC name

N-[4-cyano-3-(trifluoromethyl) phenyl]-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide

Pharmacokinetics

  • Absorption: Oral
  • Distribution: 96% protein binding

Actions

It competes with androgen for the binding of androgen receptors, consequently blocking the action of androgens of testicular and adrenal origin that stimulate the growth of malignant and normal prostatic tissue.

Dosage/Dosage form

50mg once daily per oral

Therapeutic uses

For advanced prostate cancer

Adverse effects/Side effects

Nausea, vomiting, diarrhoea, asthenia, gynaecomastia, hot flushes, pruritus, dry skin, alopecia, hirsutism, weight gain; decreased libido, impotence, intestinal lung disease; urticaria, rarely abdominal pain, CV disorders .

Interaction

Enhances effects of coumarin anticoagulants

Contraindications

Hypersensitivity

Storage

Store it at controlled room temperature.

Information

Molecular weight

430.373

Molecular formula

C18H14F4N2O4S

CAS number

90357-06-5

Precautions

Monitor liver function regularly in hepatically impaired patients on prolonged therapy. Monitoring serum levels of Prostate Specific Antigen (PSA) may be useful in evaluating the patients’ clinical progress.